Log in  First Connection?

ColorectalArchives

Genetic mechanism of β-alanine metabolic pathway affecting colorectal cancer prognosis
Colorectal
 6 min.

 Published on 08/07/2025 |  Original article (Full-text)  | Zhao Tingyu et al. | BMC Gastroenterology 2025; 25(1): 478

It is estimated that by 2022, approximately 4.82 million new instances of cancer and 3.21 million fatalities due to cancer will occur in China. Colorectal cancer (CRC) accounts for 12.3% of the total cancer incidence and 9.6% of the cancer-related deaths [1, 2]. The incidence and mortality rates of CRC,...

Tertiary lymphoid structures in the microenvironment of colorectal cancer: exploring new therapeutic targets
Colorectal
 6 min.

 Published on 01/07/2025 |  Original article (Full-text)  | Dai Nan-Nan et al. | Cancer Immunology, Immunotherapy 2025; 74(8): 245

According to the latest global cancer statistics report, colorectal cancer (CRC) maintains a significant burden worldwide, ranking as the third most commonly diagnosed cancer with 1.92 million new cases and the second leading cause of cancer-related mortality with 0.9 million deaths [1]. This epidemiological...

Lysine acetyltransferase KAT2A modulates ferroptosis during colorectal cancer development
Colorectal
 1 min.

 Published on 24/06/2025 |  Original article (Full-text)  | Zhenye Xu # et al. | Scandinavian Journal of Gastroenterology 2024; 59(4): 437-44

Histone modifications, especially the lysine acetylation, have drawn increasing attention in cancer research area. The aim of this research is to explore the molecular mechanisms underlying the regulation of lysine acetyltransferase 2 A (KAT2A) on colorectal cancer (CRC). Clinical samples were...

Engineered T cells for Colorectal Cancer
Colorectal
 1 min.

 Published on 17/06/2025 |  Original article (Full-text)  | Nurul Ainaa Adilah Rus Bakarurraini ‡ et al. | Immunotherapy 2024; 16(14-15): 987-98

Colorectal cancer (CRC) is a major contributor to global cancer incidence and mortality. Conventional treatments have limitations; hence, innovative approaches are imperative. Recent advancements in cancer research have led to the development of personalized targeted therapies and immunotherapies. Immunotherapy,...